Advertisement
Screener

Lipella Pharmaceuticals Inc. (LIPO) Capital Expenditures

2.8 / 5 stars · 68/120 Roast Me

Lipella Pharmaceuticals Inc. Capital Expenditures

Lipella Pharmaceuticals Inc. (LIPO) reported Capital Expenditures of $14.43 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2025-03-28.

Financial Statements › Cash Flow › Investing Activities

us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2025-03-28

  • Lipella Pharmaceuticals Inc. payments to acquire property, plant, and equipment for the quarter ending 2023-12-31 was $0.00.
  • Lipella Pharmaceuticals Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $14.43K.
Period endPayments to Acquire Property, Plant, and Equipment 3 monthPayments to Acquire Property, Plant, and Equipment 9 monthPayments to Acquire Property, Plant, and Equipment 12 month
2023-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28
$14.43K
10-K · filed 2025-03-28
2023-09-30$14.43K
10-Q · filed 2024-11-14